Baudax Bio (BXRX) Financials

$0.01

$0.00 (0.00%)

As on 02-May-2024 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.33	1.27	1.08	0.49	0.35	--
Cost of Revenue	5.34	7.01	2.45	1.73	--	--
Gross Profit	-5.02	-5.74	-1.37	-1.24	--	--
Operating Expenses	11.96	30.00	51.01	54.57	47.07	65.04
Operating Profit (EBIT)	-22.11	-56.81	-19.01	-74.79	-32.52	-73.54
Other Income	--	--	--	0.05	--	--
Profit before Tax	-25.71	-58.80	-19.77	-76.10	-32.56	-73.67
Provision for Tax	8.54	23.05	3.84	1.40	-14.55	-0.13
Profit after Tax (Net Income)	-7.15	-58.80	-19.77	-76.10	-18.00	-73.67
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-24.00	-58.80	-17.35	-76.10	-32.56	-73.67

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-10.24	-24.24	13.23	-14.80	-16.72	-68.35
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	11.77	12.81	24.41	65.40	63.22	80.59
Current Liabilities	19.05	21.46	15.65	18.13	7.71	22.78
Total Liabilities	39.63	10.03	53.28	68.73	54.21	35.02

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	19.25	3.69	29.78	32.02	34.08	32.51
Current Assets	1.34	6.35	23.49	36.72	20.14	2.51
Total Assets	39.63	10.03	53.28	68.73	54.21	35.02
Total Debt*	8.10	7.12	8.53	9.78	0.77	--
Net Current Assets	-17.71	-15.11	7.85	18.59	12.42	-20.27

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-27.79	-49.27	-44.06	-50.04	-59.75
Cash Flow from Investing Activities	--	-0.02	-0.19	-0.64	-1.48	-3.45
Cash from Financing Activities	--	17.18	35.01	57.30	69.27	63.20
Net Cash Inflow / Outflow	--	--	--	12.60	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-2,537.55	-236.25	725.83	42.71	112.64
ROE (%)	--	1,067.45	2,513.54	482.87	42.33	112.64
ROA (%)	-18.25	-185.74	-32.41	-123.79	-40.35	-217.36
EBIT Margin (%)	-4,974.23	-4,476.99	-1,759.81	-15,169.57	-9,317.77	--
Net Margin (%)	-2,194.48	-4,633.18	-1,830.46	-14,144.98	-5,158.45	--
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-76.03	0.18	1.19	0.41	--	--
EBIT Growth (%)	-2.53	-198.92	74.59	-129.98	42.48	-59.61
Net Profit Growth (%)	64.43	-197.41	74.02	-322.71	75.56	-20.60
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.68	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.26	-0.15	0.15	0.39	0.28	--
Close Price ($)	0.37	3.18	153.58	707.70	4,848.83	--
High Price ($)	12.24	201.81	1,485.47	7,105.07	6,306.30	--
Low Price ($)	0.30	1.55	148.61	679.70	2,501.52	--
Market Cap ($ Cr)	0.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.29	0.65	-0.66	-0.05	--
Short term debt to equity ratio	-0.54	-0.23	0.17	-0.07	-0.02	--
Current Ratio	0.07	0.30	1.50	2.03	2.61	0.11
Quick Ratio	0.07	0.30	1.18	1.86	--	--
Interest Coverage	-0.49	-2.70	-8.25	-55.03	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	26.40	50.19	10.34	--	--
Asset Turnover	0.01	0.04	0.02	0.01	0.01	--
Receivable days	--	126.21	100.27	37.78	--	--
Inventory Days	--	130.33	596.05	628.01	--	--
Payable days	--	140.57	382.50	413.75	--	--
Cash Conversion Cycle	--	115.97	313.82	252.04	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.